Menu
© Vincent Tremeau

Kyrgyzstan

Kyrgyzstan has high rates of drug-resistant tuberculosis and many people have difficulty accessing care

Kyrgyzstan is a landlocked country located in Central Asia, on the ancient Silk Road route between China and Europe.

Click map to expandThe country became independent in 1991 following the breakup of the Soviet Union.

Ethnic Kyrgyz make up the majority of the country's 5.6 million population, most being Turkic-speaking Muslims.

MSF first worked in Kyrgyzstan in 2005, provided healthcare for people who would otherwise go without.

  • {{ fact.node.field_facts }} {{ fact.node.field_facts_units }} {{ fact.node.field_post_fact }}

    {{ fact.node.field_facts_explanation }}

MSF’s work in Kyrgyzstan: 2016

The prevalence of drug-resistant tuberculosis (DR-TB) in Kyrgyzstan, one of the poorest nations in the Central Asian region, remains very high.

Kyrgyzstan has an inadequate healthcare system, experiencing frequent shortages, and today, many people struggle to access free treatment for DR-TB.

The rates of drug resistance among new TB cases are as high as one third, and in previously treated TB cases, more than half of patients have developed the drug resistant form of the disease. 

The World Health Organization estimates that there are around 2,400 people with DR-TB in the country.

south kyrgyzstan

In the south of the country, we are working in Osh, Kara Suu district, providing outpatient care for people with DR-TB, thereby limiting the time they have to spend in hospital.

Patients attend monthly medical consultations at one of three TB clinics supported by MSF.

These consultations include psychological support, which helps them adhere to the arduous treatment that can take up to two years. We also mentor Ministry of Health staff.

{{ ctaright.node.field_explanation }}

Patients with the more severe forms of the disease are admitted to hospital.

In Kara Suu hospital, which has 40 beds for DR-TB patients, we support the Ministry of Health in the diagnosis and treatment of patients.

Another team supports the follow-up of patients receiving treatment at Osh TB hospital.

A total of 90 patients were enrolled in our DR-TB programme in 2016.

In December, we also launched activities in Aidarken, in Batken oblast.

A team is developing a programme to treat people affected by diseases which have occurred because of mining extraction industries or environmental pollution in the area. 

Find out more in our International Activity Report